BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7683180)

  • 1. Fatal and nonfatal hepatotoxicity associated with flutamide.
    Wysowski DK; Freiman JP; Tourtelot JB; Horton ML
    Ann Intern Med; 1993 Jun; 118(11):860-4. PubMed ID: 7683180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide hepatotoxicity.
    Wysowski DK; Fourcroy JL
    J Urol; 1996 Jan; 155(1):209-12. PubMed ID: 7490837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
    Lin AD; Chen KK; Lin AT; Chang YH; Wu HH; Kuo JY; Huang WJ; Hsu YS; Chung HJ; Chang LS
    J Chin Med Assoc; 2003 Dec; 66(12):735-40. PubMed ID: 15015823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.
    Gomez JL; Dupont A; Cusan L; Tremblay M; Suburu R; Lemay M; Labrie F
    Am J Med; 1992 May; 92(5):465-70. PubMed ID: 1349790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic hepatitis and liver failure under therapy with flutamide].
    Lübbert C; Wiese M; Haupt R; Ruf BR
    Internist (Berl); 2004 Mar; 45(3):333-40. PubMed ID: 14997310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Sama C; Barbara L
    Dig Dis Sci; 1996 Nov; 41(11):2219-21. PubMed ID: 8943975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flutamide-induced acute hepatitis in advanced prostate cancer patients.
    Kraus I; Vitezic D; Oguic R
    Int J Clin Pharmacol Ther; 2001 Sep; 39(9):395-9. PubMed ID: 11563686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide-induced hepatotoxicity: report of a case series.
    García Cortés M; Andrade RJ; Lucena MI; Sánchez Martínez H; Fernández MC; Ferrer T; Martín-Vivaldi R; Peláez G; Suárez F; Romero-Gómez M; Montero JL; Fraga E; Camargo R; Alcántara R; Pizarro MA; García-Ruiz E; Rosemary-Gómez M
    Rev Esp Enferm Dig; 2001 Jul; 93(7):423-32. PubMed ID: 11685939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma.
    Cetin M; Demirci D; Unal A; Altinbaş M; Güven M; Unlühizarci K
    Hum Exp Toxicol; 1999 Mar; 18(3):137-40. PubMed ID: 10215102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flutamide-induced liver failure.
    Møller S; Iversen P; Franzmann MB
    J Hepatol; 1990 May; 10(3):346-9. PubMed ID: 2365984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flutamide-induced hepatotoxicity with possible potentiation by simvastatin.
    Ashar U; Desai D; Bhaduri A
    J Assoc Physicians India; 2003 Jan; 51():75-7. PubMed ID: 12693464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
    Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant hepatitis after flutamide treatment.
    Dourakis SP; Alexopoulou AA; Hadziyannis SJ
    J Hepatol; 1994 Mar; 20(3):350-3. PubMed ID: 8014445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutamide-induced liver injury: a case report.
    Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Huang YS; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):678-82. PubMed ID: 9872026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis.
    Pu YS; Liu CM; Kao JH; Chen J; Lai MK
    Eur Urol; 1999 Oct; 36(4):293-7. PubMed ID: 10473987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer.
    Dankoff JS
    J Urol; 1992 Dec; 148(6):1914. PubMed ID: 1433640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer].
    Satoh T; Egawa S; Katsuta M; Iwamura M; Uchida T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):694-6. PubMed ID: 9267134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatotoxicity of flutamide].
    Wietzke P; Münke H; Hartmann H; Ramadori G
    Z Gastroenterol; 1997 Aug; 35(8):631-5. PubMed ID: 9381745
    [No Abstract]   [Full Text] [Related]  

  • 20. Flutamide-induced acute hepatitis: investigation on the role of immunoallergic mechanisms.
    Pontiroli L; Sartori M; Pittau S; Morelli S; Boldorini R; Albano E
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):310-4. PubMed ID: 9759603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.